Tuo Hu

7PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 23, 2026
KRASG12D inhibition reprograms the tumor-induced immunosuppressive environment and enhances NK cell-mediated antitumor immunity.

|Apr 29, 2026
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer.

|Jul 24, 2025
KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression.

Chi Zhang, Runfeng Yu, Senmao Li

|Nov 25, 2023
The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling.

Jiancong Xie, Taiwei Mo, Ruibing Li

|Nov 06, 2023
Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells.

Chunbo He, Dezhen Wang, Surendra K Shukla

|Feb 25, 2023
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs.

Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song

Pageof 2

Frequent Collaborators

3 joint publications

Chunbo He

2 joint publications

Weidong Pan

2 joint publications

Zhenyu Xian

2 joint publications

Dezhen Wang